GLUE - Monte Rosa Therapeutics, Inc.
NEXT EARNINGS:
Mar 19, 2026
(in 22 days)
EPS Est: $-0.45
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.75
DETAILS
HIGH:
$37.00
LOW:
$22.00
MEDIAN:
$34.00
CONSENSUS:
$31.75
UPSIDE:
65.28%
Market Cap:
1.25B
Volume:
681,673
Avg Volume:
1,608,721
52 Week Range:
3.5-25.77
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.62
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
142
IPO Date:
2021-06-24
EPS (TTM):
-0.98
P/E Ratio:
-7.06
Revenue (TTM):
75.62M
Total Assets:
438.73M
Total Debt:
42.72M
Cash & Equiv:
224.25M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-28.8%
Debt/Equity:
0.19
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.33 | $-0.39 | +15.4% | $12.8M | $15.5M | -17.7% |
| 2025-08-07 | $-0.15 | $-0.31 | +51.6% | $23.2M | $7.8M | +198.4% |
| 2025-05-08 | $0.57 | $-0.24 | +337.5% | $84.9M | $13.6M | +526.0% |
| 2025-03-20 | $0.23 | $-0.37 | +162.2% | $60.6M | $46.7M | +30.0% |
| 2024-11-07 | $-0.29 | $-0.45 | +35.6% | $9.2M | $2.6M | +249.3% |
| 2024-08-08 | $-0.43 | $-0.50 | +14.0% | $4.7M | $1.3M | +248.1% |
| 2024-05-09 | $-0.53 | $-0.56 | +5.4% | $1.1M | $1.4M | -24.0% |
| 2024-03-14 | $-0.58 | $-0.57 | -1.8% | $8.8M | $3.5M | +148.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 75.62M | 0 | 0 | 0 | 0 | 0 |
| Net Income | (72.70M) | (135.35M) | (108.50M) | (73.96M) | (35.88M) | (8.02M) |
| EPS | -0.98 | -2.63 | -2.30 | -1.59 | -0.82 | -0.18 |
| Total Assets | 438.73M | 303.75M | 342.39M | 366.33M | 49.38M | 11.09M |
| Total Debt | 42.72M | 46.04M | 47.00M | 0 | 67.76M | 750,000 |
| Cash & Equivalents | 224.25M | 128.10M | 54.91M | 346.07M | 41.70M | 6.00M |
| Operating Cash Flow | 42.00M | (43.80M) | (92.47M) | (59.36M) | (23.05M) | (6.17M) |
| Free Cash Flow | 38.01M | (62.84M) | (105.38M) | (69.09M) | (26.44M) | (7.56M) |
| FCF per Share | 0.51 | -1.22 | -2.23 | -1.48 | -0.60 | -0.17 |
| Book Value | 222.94M | 179.25M | 271.41M | 347.51M | (48.73M) | (12.15M) |
| Cash & ST Investments | 372.15M | 232.41M | 262.83M | 346.07M | 41.70M | 6.00M |
| ROC Equity | -0.33 | -0.76 | -0.40 | -0.21 | N/A | N/A |